Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Horizon Therapeutics (NQ: HZNP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Horizon Therapeutics < Previous 1 2 3 4 5 6 7 8 9 Next > Rule 17(e) Announcement - Horizon Therapeutics plc October 06, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High October 05, 2023 Via Investor Brand Network Rule 17(d) Announcement – Horizon Therapeutics plc October 05, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) October 03, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High October 03, 2023 Via Investor Brand Network Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) October 02, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 October 02, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) September 29, 2023 From Horizon Therapeutics plc Via Business Wire New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes September 29, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) September 27, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics PLC (NASDAQ: HZNP) Sets New 52-Week High in Tuesday Session September 26, 2023 Via Investor Brand Network Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry September 26, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) September 25, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List September 19, 2023 From Horizon Therapeutics plc Via Business Wire Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata September 13, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement September 06, 2023 From Horizon Therapeutics plc Via Business Wire 3 Growth Stocks to Buy in September September 06, 2023 As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings Via MarketBeat Topics Economy Exposures Economy Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement September 05, 2023 From Horizon Therapeutics plc Via Business Wire Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition September 01, 2023 From Horizon Therapeutics plc and Amgen Via Business Wire How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? September 01, 2023 Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects. Via MarketBeat Topics Economy Exposures Interest Rates Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups August 23, 2023 From Horizon Therapeutics plc Via Business Wire Drinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners August 11, 2023 A handful of large caps have taken things to another level. These three stocks have blown past the herd — and may be market leaders for years to come. Via MarketBeat Topics Bankruptcy Economy Exposures Economy Financial Legal Horizon Therapeutics plc - Rule 2.12 Announcement August 09, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results August 08, 2023 From Horizon Therapeutics plc Via Business Wire Is Growth Priced into Amgen Stock after Earnings Beat? August 07, 2023 Amgen earnings delivered a solid earnings report after the market closed but analyst sentiment suggests that growth may already be priced into AMGN stock. Via MarketBeat Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) July 28, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces 2023 #RAREis Global Advocate Grant Recipients July 27, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Daxdilimab for the Treatment of Systemic Lupus Erythematosus (SLE) Did Not Meet Primary Endpoint July 21, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc to Release Second-Quarter 2023 Financial Results on Aug. 8, 2023 July 17, 2023 From Horizon Therapeutics plc Via Business Wire Activision Surges 10% As Judge OK's Microsoft Acquisition Deal July 12, 2023 Following a federal judge's OK of Microsoft's acquisition, Activision shares soared 10%, marking their strongest performance in over a year. The FTC can appeal. Via MarketBeat < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.